Selected research
Industry Growth & Trends
Global Oral Bordetella Vaccine Industry Growth and Trends Forecast to 2032
Market perspective
The global Oral Bordetella Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oral Bordetella Vaccine include Zoetis, Merck Animal Health, Boehringer Ingelheim(Merial) and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oral Bordetella Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oral Bordetella Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Bordetella Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Bordetella Vaccine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oral Bordetella Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oral Bordetella Vaccine Market by Company
Zoetis
Merck Animal Health
Boehringer Ingelheim(Merial)
Elanco
Oral Bordetella Vaccine Segment by Type
Combination Vaccine
Only Bordetella Vaccine
Oral Bordetella Vaccine Segment by Application
Puppies
Adult Dogs
Oral Bordetella Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Bordetella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Bordetella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Bordetella Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Bordetella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Bordetella Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Combination Vaccine
- Only Bordetella Vaccine
Applications
- Puppies
- Adult Dogs
Companies covered
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim(Merial)
- Elanco
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oral Bordetella Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oral Bordetella Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.3 Oral Bordetella Vaccine Market by Type
- 1.3.1 Combination Vaccine
- 1.3.2 Only Bordetella Vaccine
- 1.4 Global Oral Bordetella Vaccine Market Size by Type
- 1.4.1 Global Oral Bordetella Vaccine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oral Bordetella Vaccine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oral Bordetella Vaccine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oral Bordetella Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oral Bordetella Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oral Bordetella Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oral Bordetella Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oral Bordetella Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oral Bordetella Vaccine Industry Trends
- 2.2 Oral Bordetella Vaccine Industry Drivers
- 2.3 Oral Bordetella Vaccine Industry Opportunities and Challenges
- 2.4 Oral Bordetella Vaccine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oral Bordetella Vaccine Revenue (2021-2026)
- 3.2 Global Top Players by Oral Bordetella Vaccine Sales (2021-2026)
- 3.3 Global Top Players by Oral Bordetella Vaccine Price (2021-2026)
- 3.4 Global Oral Bordetella Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oral Bordetella Vaccine Major Company Production Sites & Headquarters
- 3.6 Global Oral Bordetella Vaccine Company, Product Type & Application
- 3.7 Global Oral Bordetella Vaccine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oral Bordetella Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oral Bordetella Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Oral Bordetella Vaccine Tier 1, Tier 2, and Tier 3
4 Oral Bordetella Vaccine Regional Status and Outlook
- 4.1 Global Oral Bordetella Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oral Bordetella Vaccine Historic Market Size by Region
- 4.2.1 Global Oral Bordetella Vaccine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oral Bordetella Vaccine Sales in Value by Region (2021-2026)
- 4.2.3 Global Oral Bordetella Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oral Bordetella Vaccine Forecasted Market Size by Region
- 4.3.1 Global Oral Bordetella Vaccine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oral Bordetella Vaccine Sales in Value by Region (2027-2032)
- 4.3.3 Global Oral Bordetella Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Bordetella Vaccine by Application
- 5.1 Oral Bordetella Vaccine Market by Application
- 5.1.1 Puppies
- 5.1.2 Adult Dogs
- 5.2 Global Oral Bordetella Vaccine Market Size by Application
- 5.2.1 Global Oral Bordetella Vaccine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oral Bordetella Vaccine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oral Bordetella Vaccine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oral Bordetella Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oral Bordetella Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oral Bordetella Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oral Bordetella Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oral Bordetella Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zoetis
- 6.1.1 Zoetis Company Information
- 6.1.2 Zoetis Business Overview
- 6.1.3 Zoetis Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zoetis Oral Bordetella Vaccine Product Portfolio
- 6.1.5 Zoetis Recent Developments
- 6.2 Merck Animal Health
- 6.2.1 Merck Animal Health Company Information
- 6.2.2 Merck Animal Health Business Overview
- 6.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Animal Health Oral Bordetella Vaccine Product Portfolio
- 6.2.5 Merck Animal Health Recent Developments
- 6.3 Boehringer Ingelheim(Merial)
- 6.3.1 Boehringer Ingelheim(Merial) Company Information
- 6.3.2 Boehringer Ingelheim(Merial) Business Overview
- 6.3.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolio
- 6.3.5 Boehringer Ingelheim(Merial) Recent Developments
- 6.4 Elanco
- 6.4.1 Elanco Company Information
- 6.4.2 Elanco Business Overview
- 6.4.3 Elanco Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Elanco Oral Bordetella Vaccine Product Portfolio
- 6.4.5 Elanco Recent Developments
7 North America by Country
- 7.1 North America Oral Bordetella Vaccine Sales by Country
- 7.1.1 North America Oral Bordetella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oral Bordetella Vaccine Sales by Country (2021-2026)
- 7.1.3 North America Oral Bordetella Vaccine Sales Forecast by Country (2027-2032)
- 7.2 North America Oral Bordetella Vaccine Market Size by Country
- 7.2.1 North America Oral Bordetella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oral Bordetella Vaccine Market Size by Country (2021-2026)
- 7.2.3 North America Oral Bordetella Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oral Bordetella Vaccine Sales by Country
- 8.1.1 Europe Oral Bordetella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oral Bordetella Vaccine Sales by Country (2021-2026)
- 8.1.3 Europe Oral Bordetella Vaccine Sales Forecast by Country (2027-2032)
- 8.2 Europe Oral Bordetella Vaccine Market Size by Country
- 8.2.1 Europe Oral Bordetella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oral Bordetella Vaccine Market Size by Country (2021-2026)
- 8.2.3 Europe Oral Bordetella Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oral Bordetella Vaccine Sales by Country
- 9.1.1 Asia-Pacific Oral Bordetella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oral Bordetella Vaccine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oral Bordetella Vaccine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oral Bordetella Vaccine Market Size by Country
- 9.2.1 Asia-Pacific Oral Bordetella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oral Bordetella Vaccine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oral Bordetella Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oral Bordetella Vaccine Sales by Country
- 10.1.1 South America Oral Bordetella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oral Bordetella Vaccine Sales by Country (2021-2026)
- 10.1.3 South America Oral Bordetella Vaccine Sales Forecast by Country (2027-2032)
- 10.2 South America Oral Bordetella Vaccine Market Size by Country
- 10.2.1 South America Oral Bordetella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oral Bordetella Vaccine Market Size by Country (2021-2026)
- 10.2.3 South America Oral Bordetella Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oral Bordetella Vaccine Sales by Country
- 11.1.1 Middle East and Africa Oral Bordetella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oral Bordetella Vaccine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oral Bordetella Vaccine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oral Bordetella Vaccine Market Size by Country
- 11.2.1 Middle East and Africa Oral Bordetella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oral Bordetella Vaccine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oral Bordetella Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oral Bordetella Vaccine Value Chain Analysis
- 12.1.1 Oral Bordetella Vaccine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oral Bordetella Vaccine Production Mode & Process
- 12.2 Oral Bordetella Vaccine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oral Bordetella Vaccine Distributors
- 12.2.3 Oral Bordetella Vaccine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst